Clinical Trials Logo

Clinical Trial Summary

Many women present in primary care with vaginal complaints. The best way of managing these complaints is unclear. This trial will test two different methods of managing patients with vaginal complaints. This is a pilot trial.


Clinical Trial Description

Setting: The study will be carried out at two sites within the New York City Research and Improvement Network (NYC RING) an urban Practice Based Research Network comprising 21 clinical sites. Problem: Vaginal symptoms are the most common reason for outpatient gynecological consultation, yet the management of these symptoms is not well grounded in evidence from primary care. Purpose: To prepare for a randomized clinical trial (RCT) to test whether the current standard of care for evaluating vaginal symptoms (which involves looking for specific pathogens) produces better clinical outcomes than a simpler approach, which treats patients based on their symptoms. Methods: 55 premenopausal non-pregnant adult women presenting with vaginal complaints will be randomized into two groups. Women in Group A will be managed on the basis of presenting complaint without physical examination or office laboratory work. Women in Group B will receive a physical examination and office evaluation looking for trichomonads, candida and bacterial vaginosis. They will be managed according to the clinical and office laboratory findings. Patients will be contacted by phone two weeks after consultation to assess symptom resolution, adverse reaction to drugs, satisfaction with care and treatment experiences. Patients will be screened for infection with gonorrhea and chlamydia using a urine antigen test and for trichomoniasis using vaginal culture. Patients whose tests demonstrate trichomoniasis, chlamydia or gonorrhea or who remain symptomatic at the two-week follow-up call will be re-evaluated promptly. Outcomes: AIM 1: Feasibility: The pilot will assess 1) ability to recruit and retain patients, 2) acceptability of study protocols to subjects and 3) prevalence and detection of important sexually transmitted diseases (STD's). AIM 2: Initial evidence of effectiveness: The pilot will provide data on key planned RCT outcome measurements including 1) treatment success rates (allowing estimation of future sample size), 2) need for reconsultation 3) adverse reactions, 4) medication usage and 5) patient satisfaction. Benefit to public health: This pilot study will lead to a RCT of the management of vaginal complaints in primary care. This RCT may support current practice, reinforcing the need for physical exam and laboratory testing in all patients. On the other hand, the trial may support a more limited approach that avoids a pelvic examination. This could result in substantial savings of health care dollars with equivalent clinical outcomes. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00503542
Study type Interventional
Source Agency for Healthcare Research and Quality (AHRQ)
Contact
Status Completed
Phase Phase 0
Start date February 2007
Completion date February 2008

See also
  Status Clinical Trial Phase
Completed NCT02515656 - Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis Phase 3
Recruiting NCT01420510 - Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis Phase 2/Phase 3
Completed NCT04079218 - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial Phase 4
Recruiting NCT05557318 - Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge N/A
Completed NCT01436513 - A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions. Phase 1
Completed NCT03585049 - Microscopic Images for the Development of a Rapid Vaginitis Diagnostic Device
Completed NCT04676503 - Vaginal and Rectal Colonization of Lactobacillus Crispatus NTCVAG04 Following Oral Administration in Patients With History of Vaginitis/Vaginosis N/A
Completed NCT02641717 - Validity of Patient-Collected Wet Mounts N/A
Recruiting NCT05587283 - Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women Phase 1
Not yet recruiting NCT06070454 - Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions N/A
Completed NCT02365389 - Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis Phase 2/Phase 3
Completed NCT01050465 - MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use N/A
Completed NCT05652959 - Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis
Recruiting NCT02763696 - Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota N/A
Recruiting NCT04574089 - Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository Phase 3
Recruiting NCT04816903 - Gyni™ Study With Leumit Health Services N/A
Completed NCT05670535 - Sjögren and Gynecologic Considerations
Not yet recruiting NCT06438575 - Point of Care Diagnosis of Vaginal Infections N/A
Enrolling by invitation NCT04984460 - Morphological Detection of Liquid-based Thin-layer Film-making Fungi for Fungal Vaginitis in Multiple Hospitals
Completed NCT03151928 - Diagnostic Accuracy By Providers Study